GIVAT SHMUEL, Israel, November 21, 2012 -  Cimatron Limited (NASDAQ and TASE: CIMT) today announced that its CimatronE integrated CAD/CAM software will be demonstrated at the EMAF trade show in Porto, Portugal, from November 21-24, 2012.

"The challenge facing tool shops and manufacturers worldwide is finding ways to reduce the time taken for design, NC programming, and machining," said Mr. Ira Bareket, Cimatron's VP Sales and Marketing.

"CimatronE offers a cutting-edge solution to this challenge. As a fully integrated CAD/CAM solution, CimatronE provides dramatic time savings across the entire production process, with an advanced range of capabilities tailored specifically to mold and die makers and manufacturers of discrete parts."

CimatronE's ability to enhance turnover time will be showcased at the EMAF trade show, with a live machining demonstration on a Spinner U5-1520 machine of a part programmed with CimatronE's acclaimed 5-Axis functionality. The machine will be situated at the booth of machine tool seller TecMill (booth 2A30).

CimatronE will also be displayed at EMAF at the booth of reseller S3D (booth 3B20). On display will be the software's existing CAD/CAM capabilities, as well as a preview of the new and enhanced features of CimatronE 11, to be released in 2013.

About Cimatron

With 30 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM solutions for mold, tool and die makers as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles and ultimately shorten product delivery time.

The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for mold design, die design, electrode design, 2.5 to 5 Axis milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron's subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.

Cimatron's shares are publicly traded on the NASDAQ exchange under the symbol CIMT. For more information, please visit Cimatron's web site at: http://www.cimatron.com

This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risk and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to Cimatron's plans, objectives and expected financial and operating results. The words "may," "could," "would," "will," "believe," "anticipate," "estimate," "expect," "intend," "plan," and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Cimatron's ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycles, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties related to Cimatron's business, refer to Cimatron's filings with the Securities and Exchange Commission. Cimatron cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.

For More Information Contact:

Idit Pass Lagziel
Marketing Manager
Cimatron Ltd.
Phone: +972-73-237-0298
Email: Email Contact

Ilan Erez
Chief Financial Officer  
Cimatron Ltd.    
Phone: +972-73-237-2114
Email: Email Contact